Report Content
- Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
- Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
- Executive Summary
- Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
- Drug Discovery Services Market, By Type
5.1 Introduction
5.2 Drug Metabolism and Pharmacokinetics
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Small- molecule Drugs
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Biologic Drugs
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Medicinal Chemistry Services
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6 Biology Services
5.6.1 Market Overview
5.6.2 Market Size and Forecast
- Drug Discovery Services Market, By Therapeutic Area
6.1 Introduction
6.2 Digestive System Diseases
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Cardiovascular Diseases
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Other Therapeutic Areas
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Oncology
6.5.1 Market Overview
6.5.2 Market Size and Forecast
6.6 Neurology
6.6.1 Market Overview
6.6.2 Market Size and Forecast
6.7 Infectious and Immune System Diseases
6.7.1 Market Overview
6.7.2 Market Size and Forecast
- Drug Discovery Services Market, By Company Type
7.1 Introduction
7.2 Tier 3 Pharmaceutical Companies
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Tier 2 Pharmaceutical Companies
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Tier 1 Pharmaceutical Companies
7.4.1 Market Overview
7.4.2 Market Size and Forecast
- Drug Discovery Services Market, By Process
8.1 Introduction
8.2 Hit-To-Lead Identification
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 Lead Optimization
8.3.1 Market Overview
8.3.2 Market Size and Forecast
8.4 Candidate Validation
8.4.1 Market Overview
8.4.2 Market Size and Forecast
8.5 Target Selection
8.5.1 Market Overview
8.5.2 Market Size and Forecast
8.6 Target Validation
8.6.1 Market Overview
8.6.2 Market Size and Forecast
- Drug Discovery Services Market, By Geography
9.1 Introduction
9.2 Europe
9.2.1 Europe Market, By Type
9.2.2 Europe Market, By Therapeutic Area
9.2.3 Europe Market, By Company Type
9.2.4 Europe Market, By Process
9.3 North America
9.3.1 North America Market, By Type
9.3.2 North America Market, By Therapeutic Area
9.3.3 North America Market, By Company Type
9.3.4 North America Market, By Process
9.4 Asia Pacific
9.4.1 Asia Pacific Market, By Type
9.4.2 Asia Pacific Market, By Therapeutic Area
9.4.3 Asia Pacific Market, By Company Type
9.4.4 Asia Pacific Market, By Process
9.5 Rest of The World
9.5.1 Rest of The World Market, By Type
9.5.2 Rest of The World Market, By Therapeutic Area
9.5.3 Rest of The World Market, By Company Type
9.5.4 Rest of The World Market, By Process
- Competitive Insights
10.1 Key Insights
10.2 Company Market Share Analysis
10.3 Strategic Outlook
10.3.1 Mergers & Acquisitions
10.3.2 New Product Development
10.3.3 Portfolio/Production Capacity Expansions
10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5 Others
- Company Profiles
11.1 Jubilant Lifesciences
11.1.1 Company Overview
11.1.2 Product/Service Landscape
11.1.3 Financial Overview
11.1.4 Recent Developments
11.2 Genscript Biotech Corporation
11.2.1 Company Overview
11.2.2 Product/Service Landscape
11.2.3 Financial Overview
11.2.4 Recent Developments
11.3 Piramal Enterprises Limited
11.3.1 Company Overview
11.3.2 Product/Service Landscape
11.3.3 Financial Overview
11.3.4 Recent Developments
11.4 Selvita S.A.
11.4.1 Company Overview
11.4.2 Product/Service Landscape
11.4.3 Financial Overview
11.4.4 Recent Developments
11.5 Aurigene Discovery Technologies
11.5.1 Company Overview
11.5.2 Product/Service Landscape
&a